Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
boston blog main
boston top stories
3
×
clinical trials
fda
life sciences
3
×
national blog main
deals
drug delivery
investing
medical device
san diego blog main
startups
480 biomedical
arrowmark partners
arsenal medical
beta bionics
bigfoot biomedical
biotech ipos
bob langer
boston university
chronic rhinosinusitis
congenital hyperinsulinism
covid-19
dexcom
diabetes
dyne therapeutics
edward damiano
eli lilly
eventide asset management
genzyme
george whitesides
indiana blog main
inflammation
insulinoma syndrome
ipo
keros therapeutics
lifesci venture partners
lyra therapeutics
What
developing
3
×
million
3
×
company
ipo
raised
tests
therapeutics
beta
bionics
biotech
blood
brings
closed
debut
device
diabetes
disorders
driven
drug
dyne
dyne’s
genetic
heads
key
late
levels
lyra
manages
markets
medical
medicines
monitors
muscle
muscular
new
nose
noses
pancreas
patients
persistently
Language
unset
Current search:
million
×
developing
×
" life sciences "
×
" boston top stories "
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests